NCT02108587

Optical Coherence Tomography in Staging Patients With Upper Tract Urothelial Cancer

Staging of Upper Tract Urothelial Cancer With Optical Coherence Tomography

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Case Comprehensive Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This clinical trial studies how well optical coherence tomography works in staging patients with upper-tract urothelial carcinomas. Staging describes the severity of a person's cancer based on the size and/or extent (reach) of the original (primary) tumor and whether or not cancer has spread in the body. It also helps the doctor plan the appropriate treatment. Optical coherence tomography is a procedure that uses infrared light waves to give three-dimensional pictures of structures inside tissues and organs. The pictures are made by a computer linked to the light source. Optical coherence tomography may be effective in staging patients with upper-tract urothelial carcinomas.

Detailed description

PRIMARY OBJECTIVES: I. To test the feasibility and imaging ability of optical coherence tomography (OCT) to stage upper-tract urothelial carcinomas (UTUC). OUTLINE: Patients undergo optical coherence tomography over 10-15 minutes. After completion of study, patients are followed up at 3 months.

Conditions

• Kidney/Urinary Cancer

Interventions

Type	Name	Description
DEVICE	optical coherence tomography	Undergo optical coherence tomography

Timeline

• Start date: 2016-12-01
• Primary completion: 2017-03-01
• First posted: 2014-04-09
• Last updated: 2016-10-20